PRODRUGS OF 5-FLUOROURACIL .1. HYDROLYSIS KINETICS AND PHYSICOCHEMICAL PROPERTIES OF VARIOUS N-ACYL DERIVATIVES OF 5-FLUOROURACIL

被引：49

作者：

BUUR, A ^{[1
]}

BUNDGAARD, H ^{[1
]}

机构：

[1] ROYAL DANISH SCH PHARM,DEPT PHARMACEUT CHEM AD,2 UNIV SPARKEN,DK-2100 COPENHAGEN O,DENMARK

来源：

INTERNATIONAL JOURNAL OF PHARMACEUTICS | 1984年 / 21卷 / 03期

关键词：

D O I：

10.1016/0378-5173(84)90193-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：349 / 364

页数：16

共 35 条

[1]

ALBERT A, 1971, DETERMINATION IONIZA

[2]

ALMERSJO OE, 1980, ACTA PHARMACOL TOX, V46, P329

[3] N-HYDROXYMETHYL DERIVATIVES OF NITROGEN-HETEROCYCLES AS POSSIBLE PRODRUGS .1. N-HYDROXYMETHYLATION OF URACILS [J].

BANSAL, PC ;

PITMAN, IH ;

TAM, JNS ;

MERTES, M ;

KAMINSKI, JJ .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (08) :850-854

[4]

BERENS K, 1963, ACTA BIOCHIM POL, V10, P25

[5] A SIMPLIFIED HIGH-PRESSURE LIQUID-CHROMATOGRAPHY METHOD FOR DETERMINING LIPOPHILICITY FOR STRUCTURE ACTIVITY RELATIONSHIPS [J].

BRENT, DA ;

SABATKA, JJ ;

MINICK, DJ ;

HENRY, DW .

JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (07) :1014-1020

[6]

CHLEBOWSKI RT, 1981, CANCER, V48, P1711, DOI 10.1002/1097-0142(19811015)48:8<1711::AID-CNCR2820480804>3.0.CO

[7]

2-C

[8] FLUOROURACIL THERAPY IN PATIENTS WITH CARCINOMA OF LARGE BOWEL - PHARMACOKINETIC COMPARISON OF VARIOUS RATES AND ROUTES OF ADMINISTRATION [J].

CHRISTOPHIDIS, N ;

VAJDA, FJE ;

LUCAS, I ;

DRUMMER, O ;

MOON, WJ ;

LOUIS, WJ .

CLINICAL PHARMACOKINETICS, 1978, 3 (04) :330-336

[9]

COHEN JL, 1974, CANCER CHEMOTH REP 1, V58, P723

[10] NON-LINEAR PHARMACOKINETIC MODELS FOR 5-FLUOROURACIL IN MAN - INTRAVENOUS AND INTRAPERITONEAL ROUTES [J].

COLLINS, JM ;

DEDRICK, RL ;

KING, FG ;

SPEYER, JL ;

MYERS, CE .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) :235-246

← 1 2 3 4 →